Gould Capital’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.17M Sell
28,708
-557
-2% -$77K 2.35% 10
2026
Q2
$3.76M Buy
29,265
+229
+0.8% +$26.8K 2.1% 11
2026
Q1
$3.49M Sell
29,036
-2,631
-8% -$304K 2.11% 12
2025
Q4
$3.33M Sell
31,667
-259
-0.8% -$24.3K 2.05% 14
2025
Q3
$2.68M Buy
31,926
+1,006
+3% +$82.9K 1.66% 23
2025
Q2
$2.45M Buy
30,920
+1,106
+4% +$87.9K 1.64% 23
2025
Q1
$2.68M Buy
29,814
+5,229
+21% +$488K 1.87% 22
2024
Q4
$2.45M Buy
24,585
+217
+0.9% +$22.4K 1.7% 24
2024
Q3
$2.77M Sell
24,368
-52
-0.2% -$6.18K 1.82% 24
2024
Q2
$3.02M Sell
24,420
-580
-2% -$74.7K 2.13% 20
2024
Q1
$3.3M Buy
25,000
+132
+0.5% +$16.3K 2.32% 13
2023
Q4
$2.71M Buy
24,868
+262
+1% +$27.2K 1.98% 20
2023
Q3
$2.52M Sell
24,606
-46
-0.2% -$4.96K 2.04% 19
2023
Q2
$2.84M Sell
24,652
-908
-4% -$103K 2.18% 16
2023
Q1
$2.72M Sell
25,560
-9,868
-28% -$1.07M 2.1% 18
2022
Q4
$3.93M Sell
35,428
-1,620
-4% -$166K 3.14% 6
2022
Q3
$3.19M Sell
37,048
-257
-0.7% -$22.9K 2.76% 9
2022
Q2
$3.4M Sell
37,305
-793
-2% -$70.3K 2.74% 9
2022
Q1
$3.13M Buy
38,098
+936
+3% +$73.8K 2.25% 15
2021
Q4
$2.85M Buy
+37,162
New +$2.96M 1.99% 19

Other funds holding MRK

Gould Capital's MRK Position: Q3 2026 in Review

Gould Capital reduced its Merck (MRK) stake by 1.9% in Q3 2026, selling an estimated $77K and leaving 28,708 shares worth $4.17M. The position accounts for 2.35% of the portfolio, ranked #10.

Gould Capital first reported a position in MRK in Q4 2021 and has held it in 20 quarters since. 3,958 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • Gould Capital held 28,708 shares of Merck worth $4.17M as of Q3 2026.
  • Gould Capital sold 557 Merck shares in Q3 2026, an estimated $77K.
  • Merck made up 2.35% of Gould Capital's portfolio in Q3 2026, its #10 holding.
  • Gould Capital first reported a position in Merck in Q4 2021 and has held it in 20 quarters since.
  • 3,958 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on Gould Capital's 13F filing for Q3 2026, filed 13 Nov 2026.